Overview Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308 Status: Completed Trial end date: 2018-11-13 Target enrollment: Participant gender: Summary Phase 1 trial to evaluate the drug drug interaction of CKD-501 and D308 Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical